Cargando…

p14 expression differences in ovarian benign, borderline and malignant epithelial tumors

BACKGROUND: Abnormalities in tumor suppressors p14, p16 and p53 are reported in several human cancers. In ovarian epithelial carcinogenesis, p16 and p53 show higher immunohistochemical staining frequencies in malignant tumors and are associated with poor prognoses. p14 was only analyzed in carcinoma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cabral, Vinicius Duarte, Cerski, Marcelle Reesink, Sa Brito, Ivana Trindade, Kliemann, Lucia Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075411/ https://www.ncbi.nlm.nih.gov/pubmed/27770808 http://dx.doi.org/10.1186/s13048-016-0275-2

Ejemplares similares

Quantitative analysis of the MRI features in the differentiation of benign, borderline, and malignant epithelial ovarian tumors
por: Xiao, Fuxia, et al.
Publicado: (2022)

DNA Cytometry and Nuclear Morphometry in Ovarian Benign, Borderline and Malignant Tumors
por: el Din, Amina A. Gamal, et al.
Publicado: (2015)

Microvessel Density (Chalkley Method) in a Series of 79 Gastrointestinal Stromal Tumors
por: Waengertner, Luiz Eduardo, et al.
Publicado: (2011)

Neutrophil–Lymphocyte and Platelet–Lymphocyte Ratios in Preoperative Differential Diagnosis of Benign, Borderline, and Malignant Ovarian Tumors
por: Yun, Tae Hui, et al.
Publicado: (2022)

Computed tomography-based texture assessment for the differentiation of benign, borderline, and early-stage malignant ovarian neoplasms
por: He, Ziying, et al.
Publicado: (2023)

Lack of HPV in Benign and Malignant Epithelial Ovarian Tumors in Iran
por: Farzaneh, Farah, et al.
Publicado: (2017)

Differential Expression of Progesterone Receptor Isoforms A and B in the Normal Ovary, and in Benign, Borderline, and Malignant Ovarian Tumors
por: Akahira, Jun‐ichi, et al.
Publicado: (2002)

Misdiagnosis of Streptococcus gallolyticus endocarditis
por: Starosta, Rodrigo Tzovenos, et al.
Publicado: (2016)

Diagnostic extended usefulness of RMI: comparison of four risk of malignancy index in preoperative differentiation of borderline ovarian tumors and benign ovarian tumors
por: Zhang, Shuang, et al.
Publicado: (2019)

Nuclear expression of Snail1 in borderline and malignant epithelial ovarian tumours is associated with tumour progression
por: Tuhkanen, Hanna, et al.
Publicado: (2009)

T2-weighted MRI-based radiomics for discriminating between benign and borderline epithelial ovarian tumors: a multicenter study
por: Wei, Mingxiang, et al.
Publicado: (2022)

Application of Deep Convolutional Neural Networks for Discriminating Benign, Borderline, and Malignant Serous Ovarian Tumors From Ultrasound Images
por: Wang, Huiquan, et al.
Publicado: (2021)

Epithelial borderline ovarian tumor: Diagnosis and treatment strategy
por: Ushijima, Kimio, et al.
Publicado: (2015)

Texture Analysis of Three-Dimensional MRI Images May Differentiate Borderline and Malignant Epithelial Ovarian Tumors
por: Ye, Rongping, et al.
Publicado: (2021)

Aurora-A kinase is differentially expressed in the nucleus and cytoplasm in normal Müllerian epithelium and benign, borderline and malignant serous ovarian neoplasms
por: Alkhateeb, Khaled J., et al.
Publicado: (2021)

Computed Tomography Indicators for Differentiating Stage 1 Borderline Ovarian Tumors from Stage I Malignant Epithelial Ovarian Tumors
por: Moon, Min Hoan, et al.
Publicado: (2023)

LncRNAs expression profiling in normal ovary, benign ovarian cyst and malignant epithelial ovarian cancer
por: Wang, Huan, et al.
Publicado: (2016)

Anaplastic carcinoma in ovarian seromucinous cystic tumor of borderline malignancy
por: Okumura, Toshiyuki, et al.
Publicado: (2018)

Benign multicystic peritoneal mesothelioma mimicking recurrence of an ovarian borderline tumor: a case report
por: Takemoto, Shuji, et al.
Publicado: (2012)

Immunohistochemical profiling of benign, low malignant potential and low grade serous epithelial ovarian tumors
por: Ouellet, Véronique, et al.
Publicado: (2008)

Preoperative Differentiation of Benign and Malignant Non-epithelial Ovarian Tumors: Clinical Features and Tumor Markers
por: Gomes, Tiago Augusto, et al.
Publicado: (2020)

Minimal apparent diffusion coefficient value of the solid component to differentiate borderline and malignant ovarian epithelial tumours: a preliminary report
por: Matondang, Sahat B.R.E., et al.
Publicado: (2020)

Combined use of CA125, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio for the diagnosis of borderline and malignant epithelial ovarian tumors
por: Huang, Ke, et al.
Publicado: (2023)

Expression of SEC62 Oncogene in Benign, Malignant and Borderline Melanocytic Tumors—Unmasking the Wolf in Sheep’s Clothing?
por: Müller, Cornelia S. L., et al.
Publicado: (2021)

The prevalence of malignant and borderline ovarian cancer in pre- and post-menopausal Chinese women
por: Shen, Fang, et al.
Publicado: (2017)

KNDC1 Is a Predictive Marker of Malignant Transformation in Borderline Ovarian Tumors
por: Yu, Shuqian, et al.
Publicado: (2020)

Immunohistochemical profiling of the tumour microenvironment in borderline and malignant ovarian tumours in young women
por: O'Neill, Danielle, et al.
Publicado: (2023)

MDCT-Based Radiomics Features for the Differentiation of Serous Borderline Ovarian Tumors and Serous Malignant Ovarian Tumors
por: Yu, Xin-ping, et al.
Publicado: (2021)

Controversies in borderline ovarian tumors
por: Seong, Seok Ju, et al.
Publicado: (2015)

Glutathione S-transferase expression in benign and malignant ovarian tumours.
por: Green, J. A., et al.
Publicado: (1993)

The Serum CA-125 Concentration Data Assists in Evaluating CT Imaging Information When Used to Differentiate Borderline Ovarian Tumor from Malignant Epithelial Ovarian Tumors
por: Shin, Ji-Eun, et al.
Publicado: (2011)

An integrated proteomic and glycoproteomic approach uncovers differences in glycosylation occupancy from benign and malignant epithelial ovarian tumors
por: Li, Qing Kay, et al.
Publicado: (2017)

Immunohistochemistry with apoptotic-antiapoptotic proteins (p53, p21, bax, bcl-2), c-kit, telomerase, and metallothionein as a diagnostic aid in benign, borderline, and malignant serous and mucinous ovarian tumors
por: Ozer, Hatice, et al.
Publicado: (2012)

Localisation of somatostatin and somatostatin receptors in benign and malignant ovarian tumours
por: Hall, G H, et al.
Publicado: (2002)

Predicting new-onset diabetes after minimally invasive subtotal distal pancreatectomy in benign and borderline malignant lesions of the pancreas
por: Hwang, Ho Kyoung, et al.
Publicado: (2017)

Value of conventional magnetic resonance imaging texture analysis in the differential diagnosis of benign and borderline/malignant phyllodes tumors of the breast
por: Li, Xiaoguang, et al.
Publicado: (2021)

Differential distribution of tumor-associated macrophages and Treg/Th17 cells in the progression of malignant and benign epithelial ovarian tumors
por: Zhu, Qinyi, et al.
Publicado: (2017)

Genomic aberrations in borderline ovarian tumors
por: Micci, Francesca, et al.
Publicado: (2010)

Appendiceal mucocele masquerading as an epithelial borderline ovarian tumor: a case report and literature review
por: Kim, Young Joo, et al.
Publicado: (2022)

Deep learning for the ovarian lesion localization and discrimination between borderline and malignant ovarian tumors based on routine MR imaging
por: Wang, Yida, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ev8vgtoivlgqbuc84c8vdoon4h